Advances and challenges in management of invasive mycoses
Top Cited Papers
- 1 September 2005
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 366 (9490) , 1013-1025
- https://doi.org/10.1016/s0140-6736(05)67381-3
Abstract
No abstract availableKeywords
This publication has 160 references indexed in Scilit:
- Utility of Aspergillus Antigen Detection in Specimens Other than Serum SpecimensClinical Infectious Diseases, 2004
- False‐Positive Galactomannan PlateliaAspergillusTest Results for Patients Receiving Piperacillin‐TazobactamClinical Infectious Diseases, 2004
- Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detectionThe Lancet, 2004
- Voriconazole Salvage Treatment of Invasive CandidiasisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Invasive Aspergillosis in Liver Transplant Recipients: Outcome Comparison of Therapy with Amphotericin B Lipid Complex and a Historical Cohort Treated with Conventional Amphotericin BClinical Infectious Diseases, 2003
- Candidemia at a Tertiary-Care Hospital: Epidemiology, Treatment, Clinical Outcome and Risk Factors for DeathEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile NeutropeniaClinical Infectious Diseases, 2000
- Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven AspergillosisClinical Infectious Diseases, 1999
- Disseminated Zygomycosis in a Neutropenic Patient: Successful Treatment with Amphotericin B Lipid Complex and Granulocyte Colony-Stimulating FactorClinical Infectious Diseases, 1997
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992